Trades on 2 secondary markets

Rhizome

Rhizome AI is an AI-powered regulatory research platform for pharmaceutical and medical device companies. It lets regulatory affairs teams ask questions and receive cited answers grounded in primary-source documents from health authorities worldwide (FDA, EMA, Health Canada, Swissmedic, MHRA, TGA an

developing 48.2 / 100 1 API View provider profile →

Company Regulatory Pharmaceutical Medical Devices Life Sciences Document Search

Rhizome is an API provider whose private shares are listed on 2 secondary markets: Forge Global, Nasdaq Private Market.

Rhizome publishes 1 API indexed on the APIs.io network.

Where It Trades

F Forge Global View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.